Beranda › Glomerulosklerosis Segmental Fokal › North Carolina
Uji klinis Glomerulosklerosis Segmental Fokal di North Carolina
9 studi untuk Glomerulosklerosis Segmental Fokal mencari peserta di lokasi di North Carolina.
Kota di North Carolina
Teks studi resmi (Bahasa Inggris)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #16, New Bern
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Duke University Medical Center, Durham
- Carolina Kidney Associates, Greensboro
- Cardinal Clinical Research, LLC - Shelby, Shelby
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- UNC Kidney Center- Site Number : 8400021, Chapel Hill
Menerima pesertaFase 2
Usia 16 hingga 75 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06500702Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- University of North Carolina, Chapel Hill
Menerima peserta
Hingga usia 75 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT04065438Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- University of North Carolina, Chapel Hill
Menerima peserta
Hingga usia 21 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT02235857Nephrotic Syndrome Study Network
- University of North Carolina at Chapel Hill, Chapel Hill
- Atrium Health Levine Children's Hospital, Charlotte
Menerima pesertaStudi observasional
Hingga usia 80 · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT01209000NEPTUNE Match Study
- University of North Carolina Chapel Hill, Chapel Hill
Menerima peserta
Usia 1 hingga 80 · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT04571658Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke Molecular Physiology Institute, Durham
Menerima pesertaFase 2
Usia 1 hingga 17 · Semua jenis kelamin · Diperbarui 12 Mei 2026 · NCT05003986A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- University of North Carolina, Chapel Hill
- Atrium Health, Charlotte
Menerima pesertaFase 3
Usia 12 hingga 80 · Semua jenis kelamin · Diperbarui 3 Feb 2026 · NCT05183646Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.